Sonia S. Kupfer to Pancreatic Neoplasms
This is a "connection" page, showing publications Sonia S. Kupfer has written about Pancreatic Neoplasms.
Connection Strength
2.218
-
Risk perception and surveillance uptake in individuals at increased risk for pancreatic ductal adenocarcinoma. J Med Genet. 2024 Feb 21; 61(3):270-275.
Score: 0.615
-
Outcomes of Universal Point-of-Care Genetic Testing in Diverse Patients With Pancreatic Ductal Adenocarcinoma. JCO Precis Oncol. 2023 01; 7:e2200196.
Score: 0.568
-
AGA Clinical Practice Update on Colorectal and Pancreatic Cancer Risk and Screening in BRCA1 and BRCA2 Carriers: Commentary. Gastroenterology. 2020 08; 159(2):760-764.
Score: 0.471
-
The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration. Cancer. 2024 Oct 01; 130(19):3297-3304.
Score: 0.157
-
The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals. J Natl Compr Canc Netw. 2024 04; 22(3):158-166.
Score: 0.155
-
Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance. Cancer Prev Res (Phila). 2023 06 01; 16(6):343-352.
Score: 0.146
-
Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk. Fam Cancer. 2018 10; 17(4):495-505.
Score: 0.106